References
- Hansen KMS, Spiliotopoulou A, Chhetri RK, et al. Ozonation for source treatment of pharmaceuticals in hospital wastewater – ozone lifetime and required ozone doze. Chem Eng J. 2016;290:1–8.
- Falås P, Andersen HR, Ledin A, et al. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants. Wat Sci Technol. 2012;66(4):783–791.
- Thomas KV, Dye C, Schlabach M, et al. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Monit. 2007;9:1410–1418.
- Bendz D, Paxéus NA, Ginn TR, et al. Occurence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater. 2005;122:195–204.
- Bengtsson-Palme J, Larsson DGJ. Concentrations of antibiotics predicted to select for resistant bacteria: proposed limits for environmental regulation. Environ Int. 2016;86:140–149.
- Gullberg E, Cao S, Berg OG, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7:e1002158.
- Pruden A, Larsson DGJ, Amèzquita A, et al. Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect. 2013;212:878–885.
- Korzeniewska E, Korzeniewska A, Harnisz M. Antibiotic resistant escherichia coli in hospital and municipal sewage and their emission to the environment. Ecotoxicol Environ Saf. 2013;91:96–102.
- Casas ME, Chhetri RK, Ooi G, et al. Biodegradation of pharmaceuticals in hospital wastewater by staged Moving Bed Biofilm Reactors (MBBR). Wat Res. 2015;83:293–302.
- Pauwels B, Verstraete W. The treatment of hospital wastewater: an appraisal. J Water Health. 2006;4:405–416.
- Pills. (2012) Pharmaceutical residues in the aquatic system – a challenge for the future. Available [cited 2018 Oct 14] from: http://www.pills-project.eu/PILLS_summary_english.pdf
- Nielsen U, Hastrup C, Klausen MM, et al. Removal of APIs and bacteria from hospital wastewater by MBR plus O3, O3+H2O2, PAC or ClO2. Wat Sci Technol. 2013;674:854–862.
- Grundfos BioBooster A/S. (2016) Report: full scale advanced wastewater treatment at herlev hospital treatment performance and evaluation. DHI. Available [cited 2018 Oct 14] from: www.dhigroup.com/global/news/2016/08/hospital-wastewater-from-a-pollution-problem-to-new-water-resources
- Khan GA, Berglund B, Khan KM, et al. Occurrence and abundance of antibiotics and resistance genes in rivers, canal and near drug formulation facilities–a study in Pakistan. PLoS One. 2013;8:e62712.
- Lindberg RH, Olofsson U, Marcus O, et al. Occurrence and behavior of 105 active pharmaceutical ingredients in sewage waters of a municipal sewer collection system. Water Res. 2014;8(2014):0–8.
- Grabic R, Fick J, Lindberg RH, et al. Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry. Talanta. 2012;100(2012):183–195.
- Blum KB, Norström SH, S. H. GO, et al. Removal of 30 active pharmaceutical ingredients in surface water under long-term artificial UV irradiation. Chemosphere. 2017;176:175–182.
- Pharem Biotech. (2018) pCure: frequently asked questions – what pharmaceutical residues are prioritised to degrade by pCure?. Available [cited 2018 Oct 14] from: https://www.pcure.se/en/faq
- Järhult JD. Environmental resistance development to influenza antivirals: a case exemplifying the need for a multidisciplinary one health approach including physicians. Acta Vet Scand. 2018;60(1):6.
- Kahn LH. One health and the politics of antimicrobial resistance. Baltimore: John Hopkins University Press; 2016.
- OECD. Stemming the superbug tide: just a few dollars more. Paris: OECD publishing; 2018.